Virology, Pharmacology, Virus, Coronavirus and Immunology are his primary areas of study. His Virology research is mostly focused on the topic Vero cell. He has included themes like Histone deacetylase, Cell culture, Angiogenesis and In vivo in his Pharmacology study.
Many of his studies on Virus apply to Interferon as well. His research in Coronavirus intersects with topics in Nidovirales and Coronaviridae. The concepts of his Nidovirales study are interwoven with issues in Human coronavirus NL63, Severe acute respiratory syndrome and Human coronavirus OC43.
Jindrich Cinatl focuses on Cancer research, Cell culture, Virology, Pharmacology and Immunology. His Cancer research study combines topics in areas such as Cell, Cell cycle, Apoptosis, Cisplatin and Neuroblastoma. His study in Neuroblastoma is interdisciplinary in nature, drawing from both Viability assay, Neural cell adhesion molecule, Drug resistance and Survivin.
His Cell culture research includes themes of Molecular biology, In vitro, Cell growth and Cell biology. His work in the fields of Virology, such as Virus, Human cytomegalovirus and Influenza A virus subtype H5N1, overlaps with other areas such as Coronavirus. His studies deal with areas such as Cancer cell, Doxorubicin, In vivo and ATP-binding cassette transporter as well as Pharmacology.
His primary scientific interests are in Cancer research, Drug, Cell culture, Coronavirus and Drug resistance. His work deals with themes such as Cell growth, Cisplatin, Apoptosis, Cell cycle and Neuroblastoma, which intersect with Cancer research. He interconnects Cytarabine, Cytotoxic T cell and Cardiotoxicity in the investigation of issues within Cell culture.
His Coronavirus research includes elements of Virology, Viral replication, Virus, Acute respiratory disease and RNA. In his work, Jindrich Cinatl performs multidisciplinary research in Virology and Severe acute respiratory syndrome coronavirus 2. His Virus research is multidisciplinary, incorporating elements of Interferon, Protease and Aprotinin.
Jindrich Cinatl spends much of his time researching Coronavirus, Severe acute respiratory syndrome coronavirus 2, Virology, Viral replication and Virus. His biological study spans a wide range of topics, including Viral transmission and Pandemic. He applies his multidisciplinary studies on Virology and Lung injury in his research.
His Viral replication research includes elements of Vero cell, Proteases, Protease and Cell biology. He is interested in Human cytomegalovirus, which is a field of Virus. He usually deals with Interferon and limits it to topics linked to Myocyte and Cell culture.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
Christian Drosten;Stephan Günther;Wolfgang Preiser;Sylvie van der Werf.
The New England Journal of Medicine (2003)
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
Mark Throsby;Edward van den Brink;Mandy Jongeneelen;Leo L. M. Poon.
PLOS ONE (2008)
Evidence of SARS-CoV-2 Infection in Returning Travelers from Wuhan, China.
Sebastian Hoehl;Holger Rabenau;Annemarie Berger;Marhild Kortenbusch.
The New England Journal of Medicine (2020)
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Denisa Bojkova;Kevin Klann;Benjamin Koch;Marek Widera.
Anti-tumor mechanisms of valproate: a novel role for an old drug
Roman A. Blaheta;Jindrich Cinatl.
Medicinal Research Reviews (2002)
The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions
Martin Michaelis;Hans Wilhelm Doerr;Jindrich Cinatl.
Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles
S Dreis;Florian Rothweiler;Martin Michaelis;Jindrich Cinatl.
International Journal of Pharmaceutics (2007)
Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS−Coronavirus
Gerold Hoever;Lidia Baltina;Martin Michaelis;Rimma Kondratenko.
Journal of Medicinal Chemistry (2005)
Valproic acid inhibits angiogenesis in vitro and in vivo.
Martin Michaelis;U. Ruth Michaelis;Ingrid Fleming;Tatyana Suhan.
Molecular Pharmacology (2004)
HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.
Norio Yamamoto;Rongge Yang;Yoshiyuki Yoshinaka;Shinji Amari.
Biochemical and Biophysical Research Communications (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: